Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its state-of-the-art spatial biology platform TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, an AI-powered...

NEW YORK – Artificial intelligence company Nucleai and Jefferson Health on Tuesday announced a collaboration to discover histological biomarkers that predict response to immunotherapy. Tel Aviv-based Nucleai will use its ATOM platform to...

The race to apply advanced AI tools to the war on cancer is starting to take shape, with giants like MIT and Google, as well as specialized health-tech companies like Nucleai optimizing the cancer diagnosis process. With a major shortage of...

In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help...